HOUSTON, March 16, 2021 /PRNewswire/ -- Flotek
Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today
announced results for the fourth quarter and full-year ended
December 31, 2020.
"We faced extraordinary challenges in 2020, but we remained
focused and opportunistic in the face of a global pandemic and an
extremely volatile macro-environment. While we continue to face
challenges of lower global demand and industry pressures impacting
both segments, we have improved our operational efficiencies and
found new ways to create, diversify, and grow profitable revenue,
resulting in improved adjusted EBITDA on approximately half the
revenue year-over-year," said John W.
Gibson, Jr., Chairman, President, and Chief Executive
Officer.
"It was a transformational year for Flotek for multiple reasons.
Flotek made investments in the business to create a strong
foundation for 2021 and beyond. Through our acquisition of JP3, we
diversified our revenue stream across the hydrocarbon value chain
and are well-positioned to capture long-term growth as early
adopters of the digital transformation of chemistry. Second, with
the launch of our cleaning and sanitizing product lines, we
leveraged our existing supply chain, facilities, and chemistries to
generate margin-accretive revenue. Finally, we have enhanced our
focus on ESG and are well positioned to partner with customers
seeking to improve their ESG performance with our products and
services that help to improve the safety, reliability, and
efficiency of their operations. Looking ahead, we seek to grow our
energy-focused products and services internationally, increase the
domestic market share of our products as the energy market recovers
in the latter half of 2021 and expand our ESG-related product
offerings."
Fourth Quarter and Full-Year 2020 Financial Results
- Consolidated Revenues: Flotek generated fourth quarter
2020 consolidated revenue of $12.1
million, down 5.0% from $12.7
million in the third quarter, and below $19.5 million in the fourth quarter last year.
The decline continues to be driven by volatility in the
macro-environment for U.S. onshore drilling and completion
activity, further impacted by global economic events, as well as
concerns related to COVID-19 pressuring productivity and customer
demand across the oil and gas market.
- Loss from Continuing Operations: The Company reported a
loss from continuing operations for the fourth quarter 2020 of
$17.7 million, or a loss of
$0.30 per diluted share, compared to
a loss from continuing operations in the fourth quarter 2019 of
$36.9 million, or a loss of
$0.64 per diluted share.
-
- Terpene Agreement: The loss from continuing operations
includes a loss of $9.4 million in
the fourth quarter related to the Company's amended terpene
agreement due to adjustments to the Company's expected usage of
terpene.
- Consolidated Operating Expenses: Consolidated operating
expenses (excluding depreciation and amortization) were
$24.3 million in the fourth quarter
2020, which contributed to a 42.6% decline from $42.4 million in the same period last year. The
decline was driven by a reduction in overall compensation spending,
lower discretionary spending, including professional fees,
partially offset by one-time severance charges and discretionary
bonuses.
- Corporate, General, & Administrative Expenses:
Corporate general and administrative expenses for the fourth
quarter of 2020 were $3.7 million
compared to $9.0 million for the
fourth quarter of 2019.
- Adjusted EBITDA: Adjusted EBITDA for the fourth quarter
2020 was a loss of $6.8 million,
which narrowed from the loss of $8.5
million during the fourth quarter of 2019, driven by
headcount and expense reductions in freight, equipment rentals, and
travel & entertainment.
- For the full-year 2020, Flotek generated revenue of
$53.1 million, a loss from continuing
operations of $136.5 million,
compared to revenue of $119.4
million, a loss from continuing operations of $76.1 million for the full-year 2019.
- Full-year 2020 adjusted EBITDA loss was $26.2 million, compared to an adjusted EBITDA
loss of $33.1 million for the
full-year 2019.
- For the full-year 2020, the Company's cost-cutting and process
improvement initiatives reduced annualized expenses by
approximately 40.4% across the enterprise.
Balance Sheet and Liquidity
As of December 31, 2020, the
Company had cash and equivalents of $38.7
million. As previously disclosed on April 16, 2020, the Company received a
$4.8 million loan, and JP3 received a
$0.9 million loan, both pursuant to
the Paycheck Protection Program administered by the U.S. Small
Business Administration as part of the Coronavirus Aid, Relief, and
Economic Security Act, known as the "CARES" Act.
Chemistry Technologies Segment
In the fourth quarter, sales in the Chemistry Technologies
segment declined sequentially 10.2% to $10.8
million. The decline was primarily attributed to ongoing
market volatility in the macro-environment impacting energy supply
and demand, as well as fourth quarter seasonality as several
customers in the energy chemistry business temporarily shut down
operations at year-end.
During the fourth quarter, Flotek implemented several
initiatives with the goal to be the collaborative partner of choice
for chemistry technology.
Energy Chemistry
- The Company relaunched the Flotek brand to elevate its enhanced
value approach.
- The Company is targeting a customer base with sustainable
activity and operational programs, particularly in unconventional
shale markets, whose strategic objectives align with Flotek's
proven performance and value proposition of cost-effective
chemistry solutions that can improve production at lower cost per
barrel produced.
- Flotek deployed sustainable chemistry technologies for customer
efficacy and profitability, offering cost-effective, greener and
safer chemistry solutions, for companies seeking to improve their
ESG performance.
Professional Chemistry
- Flotek expanded its product offerings and technologies and
announced the launch of its new professional chemistries brand
Flotek Protekol™, which includes a robust line of surface cleaners,
degreasers, wipes, disinfectants and sanitizers.
- As the Company builds its long-term business strategy, it has
partnered with Matt Lazlo as a
strategic advisor. A former Clorox executive, Lazlo brings more
than 25 years of experience serving in senior business, sales and
marketing roles across consumer, commercial, retail, e-Commerce and
industrial markets for Clorox.
- The Company executed a strategic agreement with a major global
manufacturer of specialty and intermediate chemicals to produce and
package EPA-registered disinfectant wipes.
Data Analytics Segment
In the fourth quarter, Data Analytics' sales improved 91.8%
sequentially to $1.3 million,
primarily driven by an increase in new sales in North America, as well as maintenance and
support services.
During the fourth quarter, Flotek continued to enhance its
offerings and increase its efficiency in delivering solutions,
while targeting new customers and markets to transform their
businesses through real-time data and analytics. Highlights
include:
- Progressed its international market entry strategy, continuing
meaningful engagement with potential customers in the Middle East, Africa and Asia, and securing its first pilot in the
Middle East.
- Implemented software development enhancements by accelerating
Artificial Intelligence and machine learning capabilities,
improving the precision of our measurement between batches of
refined hydrocarbon products – reducing time, waste and money
spent.
- Began streamlining the Company's sampling process to improve
operational efficiencies, reduce costs to customers and increase
speed to commissioning JP3's systems to customers.
Board of Directors Updates
- Kevin Brown, a director that
joined the Company's Board in June
2020 following the acquisition of JP3, passed away
unexpectedly in January. Harsha
Agadi has been appointed to the Audit Committee to replace
Mr. Brown.
- Flotek has created the Risk and Sustainability Committee, a new
committee designated to oversee risk, which will be chaired by
director Mike Fucci.
- Director Michelle M. Adams will
not stand for re-election at the 2021 annual meeting of
stockholders of the Company, due to outside demands on her time and
her schedule.
- The Board has engaged Heidrick & Struggles to conduct the
search for a replacement director.
Conference Call Details
Flotek will host a conference call on Tuesday, March 16, 2021, at 4:00 pm CDT (5:00 p.m.
EDT) to discuss its fourth quarter and full-year operating
results ended December 31, 2020. To
participate in the call, participants should dial 844-835-9986
approximately five minutes prior to the start of the call. The call
can also be accessed from Flotek's website at
www.flotekind.com.
About Flotek Industries, Inc.
Flotek Industries, Inc. is a technology-driven, specialty
chemistry and data company that serves customers across industrial,
commercial and consumer markets. Flotek's Chemistry Technologies
segment develops, manufactures, packages, distributes, delivers,
and markets high-quality sanitizers and disinfectants for
commercial, governmental and personal consumer use. Additionally,
Flotek empowers the energy industry to maximize the value of their
hydrocarbon streams and improve return on invested capital through
its real-time data platforms and chemistry technologies. Flotek
serves downstream, midstream and upstream customers, both domestic
and international. Flotek is a publicly traded company
headquartered in Houston, Texas,
and its common shares are traded on the New York Stock Exchange
under the ticker symbol "FTK." For additional information, please
visit Flotek's web site at www.flotekind.com.
Forward-Looking Statements
Certain statements set forth in this press release constitute
forward-looking statements (within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934) regarding Flotek Industries, Inc.'s business,
financial condition, results of operations and prospects. Words
such as will, continue, expects, anticipates, intends, plans,
believes, seeks, estimates and similar expressions or variations of
such words are intended to identify forward-looking statements, but
are not the exclusive means of identifying forward-looking
statements in this press release. Although forward-looking
statements in this press release reflect the good faith judgment of
management, such statements can only be based on facts and factors
currently known to management. Consequently, forward-looking
statements are inherently subject to risks and uncertainties, and
actual results and outcomes may differ materially from the results
and outcomes discussed in the forward-looking statements.
Further information about the risks and uncertainties that
may impact the Company are set forth in the Company's most recent
filing with the Securities and Exchange Commission on Form 10-K
(including, without limitation, in the "Risk Factors" section
thereof), and in the Company's other SEC filings and publicly
available documents. Readers are urged not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. The Company undertakes no
obligation to revise or update any forward-looking statements in
order to reflect any event or circumstance that may arise after the
date of this press release.
Flotek Industries,
Inc.
|
Unaudited
Condensed Consolidated Balance Sheets
|
(in thousands,
except share data)
|
|
|
|
|
|
December 31,
2020
|
|
December 31,
2019
|
ASSETS
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
38,660
|
|
$
100,575
|
Restricted
cash
|
664
|
|
663
|
Accounts receivable,
net of allowance for doubtful accounts of $1,316
|
|
|
|
and $1,527 at
December 31, 2020 and December 31, 2019, respectively
|
11,764
|
|
15,638
|
Inventories,
net
|
11,837
|
|
23,210
|
Income taxes
receivable
|
403
|
|
631
|
Other current
assets
|
3,127
|
|
13,191
|
Total current
assets
|
66,455
|
|
153,908
|
Property and
equipment, net
|
9,087
|
|
39,829
|
Operating lease
right-of-use assets
|
2,320
|
|
16,388
|
Goodwill
|
8,092
|
|
—
|
Deferred tax assets,
net
|
223
|
|
152
|
Other intangible
assets, net
|
-
|
|
20,323
|
Other long-term
assets
|
33
|
|
—
|
TOTAL
ASSETS
|
$
86,210
|
|
$
230,600
|
LIABILITIES AND
STOCKHOLDERS' & EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$
5,787
|
|
$
16,231
|
Accrued
liabilities
|
18,275
|
|
24,552
|
Income taxes
payable
|
21
|
|
—
|
Interest
payable
|
34
|
|
—
|
Current portion of
operating lease liabilities
|
636
|
|
486
|
Current portion of
finance lease liabilities
|
60
|
|
55
|
Current portion of
long-term debt
|
4,048
|
|
—
|
Total current
liabilities
|
28,861
|
|
41,324
|
Deferred revenue,
long-term
|
117
|
|
—
|
Long-term operating
lease liabilities
|
8,348
|
|
16,973
|
Long-term finance
lease liabilities
|
96
|
|
158
|
Long-term
debt
|
1,617
|
|
—
|
Deferred tax
liabilities, net
|
-
|
|
116
|
Total
liabilities
|
39,039
|
|
58,571
|
Stockholders'
Equity:
|
|
|
|
Preferred stock,
$0.0001 par value, 100,000 shares authorized; no shares
issued
|
|
|
|
and
outstanding
|
—
|
|
—
|
Common stock, $0.0001
par value, 140,000,000 shares authorized; 78,669,414
|
|
|
|
shares issued and
73,088,494 shares outstanding at December 31, 2020;
|
|
|
|
63,656,897
shares issued and 59,511,416 shares outstanding at
December 31, 2019
|
8
|
|
6
|
Additional paid-in
capital
|
359,721
|
|
347,564
|
Accumulated other
comprehensive (loss) income
|
(19)
|
|
181
|
Accumulated
deficit
|
(278,688)
|
|
(142,238)
|
Treasury stock, at
cost; 5,580,920 and 4,145,481 shares at December 31,
2020
|
|
|
|
and 2019,
respectively
|
(33,851)
|
|
(33,484)
|
Total stockholders'
equity
|
47,171
|
|
172,029
|
TOTAL LIABILITIES
AND STOCKHOLDERS' EQUITY
|
$
86,210
|
|
$
230,600
|
|
|
|
|
(1) Results of the
Company's Consumer and Industrial Chemistry Technologies ("CICT")
segment are presented as discontinued operations
for all periods.
(2) Prior periods presented for 2019 have been adjusted to reflect
revisions to results determined not to be material to those prior
periods.
|
Flotek Industries,
Inc.
|
Unaudited
Condensed Consolidated Statements of Operations
|
(in thousands,
except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
Twelve Months
Ended
|
|
12/31/2020
|
|
12/31/2019
|
|
9/30/2020
|
|
12/31/2020
|
|
12/31/2019
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
$
12,106
|
|
$
19,526
|
|
$
12,739
|
|
$
53,141
|
|
$
119,353
|
Costs and
expenses:
|
|
|
|
|
|
|
|
|
|
Operating expenses
(excluding depreciation and amortization)
|
24,327
|
|
42,389
|
|
29,466
|
|
88,266
|
|
148,100
|
Corporate general and
administrative
|
3,744
|
|
8,955
|
|
2,679
|
|
16,311
|
|
27,975
|
Depreciation and
amortization
|
235
|
|
2,028
|
|
518
|
|
3,412
|
|
8,465
|
Research and
development
|
1,540
|
|
2,205
|
|
1,480
|
|
7,213
|
|
8,863
|
(Gain) loss on
disposal of long-lived assets
|
(2)
|
|
354
|
|
(37)
|
|
(94)
|
|
1,450
|
Impairment of fixed
and long-lived assets
|
-
|
|
-
|
|
12,521
|
|
69,975
|
|
-
|
Impairment of
goodwill
|
-
|
|
-
|
|
11,706
|
|
11,706
|
|
-
|
Total costs and
expenses
|
29,844
|
|
55,931
|
|
58,333
|
|
196,789
|
|
194,853
|
Loss from
operations
|
(17,738)
|
|
(36,405)
|
|
(45,594)
|
|
(143,648)
|
|
(75,500)
|
Other (expense)
income:
|
|
|
|
|
|
|
|
|
|
Gain on lease
termination
|
-
|
|
-
|
|
-
|
|
576
|
|
-
|
Interest
expense
|
(20)
|
|
(4)
|
|
(19)
|
|
(60)
|
|
(2,019)
|
Other income
(expense), net
|
179
|
|
469
|
|
291
|
|
503
|
|
1,708
|
Total other income
(expense)
|
159
|
|
465
|
|
272
|
|
1,019
|
|
(311)
|
Loss before income
taxes
|
(17,579)
|
|
(35,940)
|
|
(45,322)
|
|
(142,629)
|
|
(75,811)
|
Income tax benefit
(expense)
|
(102)
|
|
(956)
|
|
81
|
|
6,179
|
|
(262)
|
Loss from
continuing operations
|
(17,681)
|
|
(36,896)
|
|
(45,241)
|
|
(136,450)
|
|
(76,073)
|
Income (loss) from
discontinued operations, net of tax
|
-
|
|
(2,425)
|
|
-
|
|
-
|
|
42,158
|
Net
loss
|
(17,681)
|
|
(39,321)
|
|
(45,241)
|
|
(136,450)
|
|
(33,915)
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted
earnings (loss) per common share:
|
|
|
|
|
|
|
|
|
|
Continuing
operations
|
$
(0.30)
|
|
$
(0.64)
|
|
$
(0.66)
|
|
$
(2.00)
|
|
$
(1.29)
|
Discontinued
operations, net of tax
|
-
|
|
(0.04)
|
|
-
|
|
-
|
|
0.72
|
Basic and diluted
earnings (loss) per common share
|
$
(0.30)
|
|
$
(0.68)
|
|
$
(0.66)
|
|
$
(2.00)
|
|
$
(0.57)
|
Weighted average
common shares:
|
|
|
|
|
|
|
|
|
|
Weighted average
common shares used in computing basic and diluted
loss per common share
|
59,058
|
|
58,403
|
|
68,217
|
|
68,312
|
|
58,750
|
|
|
|
|
|
|
|
|
|
|
(1) Results of the
Company's Consumer and Industrial Chemistry Technologies ("CICT")
segment are presented as discontinued operations for all
periods.
(2) Prior periods presented for 2019 have been adjusted to
reflect revisions to results determined not to be material to those
prior periods.
|
FLOTEK INDUSTRIES,
INC.
|
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(in
thousands)
|
|
|
|
|
|
Years ended
December 31,
|
|
2020
|
|
2019
|
Cash flows from
operating activities:
|
|
|
|
Net loss
|
$
(136,450)
|
|
$
(33,915)
|
Income from
discontinued operations, net of tax
|
-
|
|
42,158
|
Loss from continuing
operations
|
(136,450)
|
|
(76,073)
|
Adjustments to
reconcile loss from continuing operations to net cash
used in operating activities:
|
|
|
|
Change in fair value
of contingent consideration
|
2,716
|
|
-
|
Depreciation and
amortization
|
3,412
|
|
8,465
|
Amortization of
deferred financing costs
|
-
|
|
1,428
|
Provision for
doubtful accounts
|
652
|
|
512
|
Provision for excess
and obsolete inventory
|
12,261
|
|
5,659
|
Impairment of fixed
assets
|
30,178
|
|
-
|
(Gain) loss on sale
of assets
|
(561)
|
|
1,450
|
Impairment of
goodwill
|
11,706
|
|
-
|
Impairment of
right-of-use assets
|
7,434
|
|
-
|
Impairment of
intangible assets
|
32,363
|
|
-
|
Stock compensation
expense
|
3,044
|
|
4,235
|
Deferred income tax
(benefit) provision
|
(187)
|
|
18,307
|
Reduction in tax
benefit related to stock-based awards
|
-
|
|
24
|
Non-cash lease
expense
|
356
|
|
740
|
Changes in current
assets and liabilities:
|
|
|
|
Accounts receivable,
net
|
3,556
|
|
20,993
|
Inventories
|
3,955
|
|
(727)
|
Income taxes
receivable
|
182
|
|
2,546
|
Other current
assets
|
1,026
|
|
2,579
|
Other long-term
assets
|
(16)
|
|
3,286
|
Accounts
payable
|
(12,323)
|
|
1,131
|
Accrued
liabilities
|
(11,260)
|
|
908
|
Income taxes
payable
|
84
|
|
-
|
Interest payable
|
34
|
|
(8)
|
Net cash used in
operating activities
|
(47,838)
|
|
(4,545)
|
Cash flows from
investing activities:
|
|
|
|
Capital
expenditures
|
(1,425)
|
|
(2,411)
|
Proceeds from sale of
businesses
|
9,907
|
|
155,498
|
Proceeds from sale of
assets
|
109
|
|
240
|
Payments for
acquisition, net of cash acquired
|
(26,284)
|
|
-
|
Purchase of patents
and other intangible assets
|
(8)
|
|
(614)
|
Net cash (used in)
provided by investing activities
|
(17,701)
|
|
152,713
|
Cash flows from
financing activities:
|
|
|
|
Borrowings on
revolving credit facility
|
-
|
|
42,984
|
Repayments on
revolving credit facility
|
-
|
|
(92,715)
|
Payment for
contingent consideration
|
(1,200)
|
|
-
|
Proceeds from
Paycheck Protection Program loan
|
4,788
|
|
-
|
Payments for finance
leases
|
(70)
|
|
(51)
|
Purchase of treasury
stock
|
(253)
|
|
(247)
|
Proceeds from sale of
common stock
|
462
|
|
35
|
Net cash provided by
(used in) financing activities
|
3,727
|
|
(49,994)
|
Discontinued
operations:
|
|
|
|
Net cash used in
operating activities
|
-
|
|
(322)
|
Net cash provided by
investing activities
|
-
|
|
337
|
Net cash flows
provided by discontinued operations
|
-
|
|
15
|
Effect of changes
in exchange rates on cash and cash equivalents
|
(102)
|
|
5
|
Net change in
cash, cash equivalents and restricted cash
|
(61,914)
|
|
98,194
|
Cash, cash
equivalents at beginning of period
|
100,575
|
|
3,044
|
Restricted cash at
the beginning of the period
|
663
|
|
663
|
Cash and cash
equivalents and restricted cash at beginning of
period
|
101,238
|
|
3,707
|
Cash and Cas
equivalents at end of period
|
38,660
|
|
100,575
|
Restricted cash at
the end of period
|
664
|
|
663
|
Cash, cash
equivalents and restricted cash at end of period
|
$
39,324
|
|
$
101,238
|
Flotek Industries,
Inc.
|
Unaudited
Reconciliation of Non-GAAP Items and Non-Cash Items Impacting
Earnings
|
(in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Loss from
Continuing Operations and Reconciliation to Adjusted EBITDA
(Non-GAAP)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
Twelve Months
Ended
|
|
|
|
|
|
12/31/2020
|
|
12/31/2019
|
|
9/30/2020
|
|
12/31/2020
|
|
12/31/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from
Continuing Operations (GAAP)
|
|
|
$
(17,681)
|
|
$
(36,896)
|
|
$
(45,241)
|
|
$
(136,450)
|
|
$
(76,073)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
Expense
|
|
|
|
20
|
|
4
|
|
19
|
|
60
|
|
2,019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
Income
|
|
|
|
(10)
|
|
(405)
|
|
(206)
|
|
(473)
|
|
(1,888)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax Benefit
(Expense)
|
|
|
102
|
|
956
|
|
(81)
|
|
(6,179)
|
|
262
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and
Amortization
|
|
|
235
|
|
2,028
|
|
518
|
|
3,412
|
|
8,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of Fixed
and Long Lived Assets
|
|
-
|
|
-
|
|
12,521
|
|
69,975
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of
Goodwill
|
|
|
-
|
|
-
|
|
11,706
|
|
11,706
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
(Non-GAAP)
|
|
|
|
$
(17,334)
|
|
$
(34,313)
|
|
$
(20,764)
|
|
$
(57,949)
|
|
$
(67,215)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Compensation
Expense
|
|
|
833
|
|
1,409
|
|
690
|
|
3,045
|
|
4,235
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance and
Retirement
|
|
|
334
|
|
3,753
|
|
749
|
|
3,848
|
|
6,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory
Write-Down
|
|
|
9,436
|
|
20,188
|
|
9,565
|
|
21,294
|
|
20,188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M&A Transaction
Costs
|
|
|
(371)
|
|
-
|
|
3,219
|
|
3,346
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory
Step-Up
|
|
|
108
|
|
-
|
|
81
|
|
344
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholder-Related
Activities
|
|
|
-
|
|
-
|
|
-
|
|
-
|
|
646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) loss on
Disposal of Assets
|
|
|
(2)
|
|
355
|
|
(37)
|
|
(94)
|
|
1,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on Lease
Termination
|
|
|
-
|
|
-
|
|
-
|
|
(576)
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operations Related
Contract
|
|
|
-
|
|
-
|
|
-
|
|
-
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COVID-19 Related
Costs
|
|
|
202
|
|
-
|
|
-
|
|
202
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued Legal
Fees
|
|
|
2
|
|
132
|
|
14
|
|
338
|
|
578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
(Non-GAAP)
|
|
|
|
$
(6,792)
|
|
$
(8,476)
|
|
$
(6,483)
|
|
$
(26,202)
|
|
$
(33,115)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Management
believes that adjusted EBITDA for the three and twelve months ended
December 31, 2020 and December 31, 2019, and the three months ended
December 31, 2020, is useful to investors to assess and understand
operating performance, especially when comparing those results with
previous and subsequent periods. Management views the expenses
noted above to be outside of the Company's normal operating
results. Management analyzes operating results without the impact
of the above items as an indicator of performance, to identify
underlying trends in the business and cash flow from continuing
operations, and to establish operational goals.
|
(2) Results of the
Company's Consumer and Industrial Chemistry Technologies ("CICT")
segment are presented as discontinued operations for all
periods.
|
(3) Prior periods
presented for 2019 have been adjusted to reflect revisions to
results determined not to be material to those prior
periods.
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/flotek-announces-q4-and-full-year-2020-results-301248041.html
SOURCE Flotek Industries, Inc.